Impact of Anti-Estrogen Therapy on Early Vascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer

被引:0
|
作者
Ansari, Ahmer
Levine, Beverly
Douglas, Emily
Ansley, Katherine
Melin, Susan
Park, Carolyn
Richardson, Karl
D'Agostino, Ralph
Jordan, Jennifer
Thomas, Alexandra
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P1-12-01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-12-01
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Impact of Anti-Estrogen Therapy on Early Cardiovascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer
    Douglas, Emily
    Levine, Beverly
    Ansari, Ahmer
    Ansley, Katherine
    Melin, Susan
    Park, Carolyn J.
    Richardson, Karl
    Hatcher, Sarah
    D'Augstino, Ralph B., Jr.
    Jordan, Jennifer H.
    Thomas, Alexandra
    [J]. CLINICAL BREAST CANCER, 2024, 24 (04) : e289 - e296
  • [2] Anti-estrogen Therapy and Fertility Preservation in Premenopausal Breast Cancer Patients: a Review
    Marcela Mazo Canola
    Virginia G. Kaklamani
    [J]. Current Breast Cancer Reports, 2022, 14 : 29 - 36
  • [3] Anti-estrogen Therapy and Fertility Preservation in Premenopausal Breast Cancer Patients: a Review
    Mazo Canola, Marcela
    Kaklamani, Virginia G.
    [J]. CURRENT BREAST CANCER REPORTS, 2022, 14 (02) : 29 - 36
  • [4] ENDOCRINE CONSEQUENCES OF CONTINUOUS ANTI-ESTROGEN THERAPY WITH TAMOXIFEN IN PREMENOPAUSAL WOMEN
    SHERMAN, BM
    CHAPLER, FK
    CRICKARD, K
    WYCOFF, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02): : 398 - 404
  • [5] LHRH AGONIST ZOLADEX AND ANTI-ESTROGEN TAMOXIFEN - A RATIONAL COMBINATION IN PREMENOPAUSAL WOMEN WITH BREAST-CANCER
    ROBERTSON, JFR
    WALKER, K
    NICHOLSON, RI
    BLAMEY, RW
    [J]. BRITISH JOURNAL OF SURGERY, 1988, 75 (12) : 1271 - 1271
  • [6] The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer
    Kathleen Van Asten
    An Poppe
    Kevin Punie
    Lynn Jongen
    Anneleen Lintermans
    Hans Wildiers
    Patrick Neven
    [J]. Current Treatment Options in Oncology, 2015, 16
  • [7] The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer
    Van Asten, Kathleen
    Poppe, An
    Punie, Kevin
    Jongen, Lynn
    Lintermans, Anneleen
    Wildiers, Hans
    Neven, Patrick
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (07)
  • [8] ADJUVANT ENDOCRINE THERAPY FOR OPERABLE BREAST-CANCER USING THE ANTI-ESTROGEN MEPITIOSTANE - A PRELIMINARY-REPORT
    NOMURA, Y
    YAMAGATA, J
    TAKENAKA, K
    KANDA, K
    [J]. GANN, 1980, 71 (04): : 548 - 556
  • [9] ENDOCRINE ADJUVANT THERAPY WITH ANTI-ESTROGEN, MEPITIOSTANE, IN OPERABLE BREAST-CANCER PATIENTS ON BASIS OF ESTROGEN-RECEPTOR ASSAY
    NOMURA, Y
    YAMAGATA, J
    KONDO, H
    TAKENAKA, K
    [J]. GANN, 1978, 69 (02): : 281 - 282
  • [10] Pathologic Changes in Breast Cancer After Anti-Estrogen Therapy
    Samarnthai, Norasate
    Elledge, Richard
    Prihoda, Thomas J.
    Huang, Jian
    Massarweh, Suleiman
    Yeh, I-Tien
    [J]. BREAST JOURNAL, 2012, 18 (04): : 362 - 366